
German Drug Advertising Act – Advertising guidelines for the pharmaceutical and healthcare industry
Contents
What does the German Drug Advertising Act regulate?
The German Drug Advertising Act, or Heilmittelwerbegesetz (HWG), governs advertising for medicines, medical devices and certain other health-related products and treatments in Germany. It particularly addresses misleading claims and inappropriate influence on health decisions. The applicable rules depend on the offering, audience and presentation.
The HWG operates alongside the German Medicinal Products Act and competition law. Marketing teams need to consider it when preparing advertisements, websites, brochures, events and social media content. A scientific presentation can still constitute advertising when its overall context promotes sales.
Which audiences must teams distinguish?
The broad professional audience defined in section 2 HWG is not identical to the permitted recipients of prescription-medicine advertising. Section 10 HWG identifies doctors, dentists, veterinarians, pharmacists and people legally trading in those medicines. Simply belonging to a healthcare profession does not qualify someone for every prescription-product campaign.
Non-prescription medicines may, for example, be advertised to the public, subject to applicable restrictions. Non-prescription status is not a blanket permission to advertise. Food supplements also have their own food-law requirements.
Which claims and presentations need particular care?
Misleading statements about efficacy or safety are prohibited. A favorable study finding must not be transferred to a different use without considering the population, comparator and important limitations. Section 3a HWG addresses advertising for unauthorized medicines and uses outside the authorization.
Section 11 contains additional public-advertising restrictions, including particular recommendations by well-known people, misleading disease narratives and certain third-party statements. Patient experiences therefore need assessment in their actual context. Mandatory information under section 4 must also be considered for the particular advertising format.
How can marketing teams apply these rules?
A practical review starts with the intended audience and promotional purpose. Teams then assess claims, supporting evidence, required information and presentation together. On restricted websites, access controls must match the permitted audience and cover downloads and direct requests for protected resources.
A login, platform approval or internal material approval does not replace substantive review. Changes to advertisements, landing pages and linked resources should be considered together because the overall impression also matters.
Conclusion: Assess audience, claim and context together
The HWG provides a framework for responsible healthcare advertising. Sound planning connects a permitted audience with supportable statements and an appropriate presentation. Breaches may lead to competition-law injunctions; criminal or administrative penalties depend on the particular statutory provision.

